DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.

Search Results

Tip

Your search for Pulmonary Disease | All Regions returned 1 study.


Active, currently enrolling Who can join A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors Keywords: Lung Neoplasms,; Carcinoma,; Non-Small-Cell Lung,; Respiratory Tract Neoplasms,;… Study Type: INTERVENTIONAL \| Region: California - Northern

Active, currently enrolling Who can join

A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors

Keywords: Lung Neoplasms,; Carcinoma,; Non-Small-Cell Lung,; Respiratory Tract Neoplasms,;…
Study Type: INTERVENTIONAL | Region: California - Northern

Search Results

Saved Studies

A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors